These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7214664)

  • 1. Clinical trials of misonidazole in the United States.
    Wasserman TH; Stetz J; Phillips TL
    Cancer Clin Trials; 1981; 4(1):7-16. PubMed ID: 7214664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation Therapy Oncology Group clinical trials with misonidazole.
    Wasserman TH; Stetz J; Phillips TL
    Cancer; 1981 May; 47(10):2382-90. PubMed ID: 7023642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical trials of hypoxic cell sensitizer misonidazole].
    Onoyama Y
    Gan No Rinsho; 1983 May; 29(6):718-25. PubMed ID: 6348345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I trial of intravenous L-phenylalanine mustard plus the sensitizer misonidazole.
    Coleman CN; Friedman MK; Jacobs C; Halsey J; Ignoffo R; Leibel S; Hirst VK; Gribble M; Carter SK; Phillips TL
    Cancer Res; 1983 Oct; 43(10):5022-5. PubMed ID: 6883348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical testing of the radiosensitizer RO-07-0582 (misonidazole). Dose tolerance, toxicity and pharmacokinetic studies, preliminary report (author's transl)].
    Bataini JP; Bernier J; de Narbonne J; Brugère J; Jaulerry C; Brunin F
    Bull Cancer; 1978; 65(4):482-5. PubMed ID: 371710
    [No Abstract]   [Full Text] [Related]  

  • 6. Preliminary results of RTOG phase I/II study of misonidazole and radiation for bladder cancer.
    Mohiuddin M; Kramer S; Phillips T; Soberon M; Forgione H
    Am J Clin Oncol; 1982 Oct; 5(5):551-4. PubMed ID: 7180834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trials with hypoxic cell sensitizers-the European experience.
    Dische S
    Prog Clin Biol Res; 1983; 132D():293-303. PubMed ID: 6356146
    [No Abstract]   [Full Text] [Related]  

  • 8. Misonidazole in the clinic at Mount Vernon.
    Dische S
    Cancer Clin Trials; 1980; 3(2):175-8. PubMed ID: 7000388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Postoperative radiotherapy of astrocytomas grade 3 and 4 with the radiosensitizer misonidazole. -End results of a multicentric controlled German study].
    Sack H; Calcanis A; Godehardt E; Weidtman V; Zülch KJ; Ammon J; Bamberg M; Herbst M; Keim H; Kleibel F; Makoski HB; Potthoff PC; Schlegel G; Schnepper E
    Strahlentherapie; 1982 Aug; 158(8):466-9. PubMed ID: 6753245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Misonidazole peripheral neuropathy: its relationship to plasma concentration and other drugs.
    Walker MD; Strike TA
    Cancer Clin Trials; 1980; 3(2):105-9. PubMed ID: 6253094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of the effect of misonidazole in conjunction with radiotherapy for the treatment of head and neck cancer. MRC working party on misonidazole in head and neck cancer.
    Br J Radiol; 1984 Jul; 57(679):585-95. PubMed ID: 6329395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New side effect of the hypoxic cell sensitizer, misonidazole.
    Partington J; Koziol D; Chapman D; Rabin H; Urtasun RC
    Cancer Treat Rep; 1979 Jan; 63(1):123-5. PubMed ID: 217536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of adjuvant misonidazole in the definitive irradiation of advanced head and neck squamous cancer: an RTOG pilot study (#78-02).
    Fazekas JT; Goodman RL; McLean CJ
    Int J Radiat Oncol Biol Phys; 1981 Dec; 7(12):1703-8. PubMed ID: 7333912
    [No Abstract]   [Full Text] [Related]  

  • 14. Palliation of liver metastases with combined hepatic irradiation and misonidazole. Results of a Radiation Therapy Oncology Group Phase I-II study.
    Leibel SA; Order SE; Rominger CJ; Asbell SO
    Cancer Clin Trials; 1981; 4(3):285-93. PubMed ID: 6169464
    [No Abstract]   [Full Text] [Related]  

  • 15. The Cambridge glioma trial of misonidazole and radiation therapy with associated pharmacokinetic studies.
    Bleehen NM
    Cancer Clin Trials; 1980; 3(3):267-73. PubMed ID: 7002338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between the neurotoxicity of the hypoxic cell radiosensitizer SR 2508 and the pharmacokinetic profile.
    Coleman CN; Halsey J; Cox RS; Hirst VK; Blaschke T; Howes AE; Wasserman TH; Urtasun RC; Pajak T; Hancock S
    Cancer Res; 1987 Jan; 47(1):319-22. PubMed ID: 3024818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Misonidazole in patients receiving radical radiotherapy: pharmacokinetic effects of phenytoin, tumor response and neurotoxicity.
    Moore JL; Paterson IC; Dawes PJ; Henk JM
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):361-4. PubMed ID: 7107352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A national trial on the treatment of invasive bladder cancer.
    Arnold EP; Bailey C; Burry AF; Bydder PV; Firth LA; Gowland S; Gray AJ; Mcllroy R
    N Z Med J; 1981 Apr; 93(682):273-5. PubMed ID: 7019784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Misonidazole in the preoperative and radical radiotherapy of bladder cancer.
    Awwad HK; El Merzabani MM; El Badawy S; Ezzat S; Akoush H; Abd El Moneim H; Saiid A; Soliman O; Khafagy M; Burgers MV
    Cancer Clin Trials; 1980; 3(3):275-80. PubMed ID: 7438324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Misonidazole combined with large-fraction pelvic irradiation in the treatment of patients with advanced pelvic malignancies. Preliminary report of an ongoing RTOG phase I-II study.
    Meoz RT; Spanos WJ; Doss L; Johnson R; Wasserman TH
    Am J Clin Oncol; 1983 Aug; 6(4):417-22. PubMed ID: 6191560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.